Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Griebel

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Pharmacology, Biochemistry, and Behavior|June 7, 2005
CB1 receptor antagonists for the treatment of nicotine addictionCaroline Cohen, Ercem Kodas, Guy Griebel
Physiology & Behavior|September 27, 2005
Long-term impaired memory following predatory stress in miceWissam El Hage, Guy Griebel, Catherine Belzung
Pharmacology, Biochemistry, and Behavior|March 25, 2008
Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depressionDavid H Overstreet, Jeanne Stemmelin, Guy Griebel
The Journal of Clinical Psychiatry|November 14, 2012
The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studiesGuy Griebel, Sandra Beeské, Stephen M Stahl
Pharmacology, Biochemistry, and Behavior|March 2, 2011
The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in miceAlexandre Urani, Julie Philbert, Caroline Cohen, et al.
Behavioural Brain Research|May 8, 2012
Awakening properties of newly discovered highly selective H₃ receptor antagonists in ratsGuy Griebel, Michel Decobert, Agnès Jacquet, et al.
Pharmacology, Biochemistry, and Behavior|May 18, 2010
Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depressionDavid H Overstreet, V M Naimoli, Guy Griebel
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 9, 2003
Conditioning and residual emotionality effects of predator stimuli: some reflections on stress and emotionD Caroline Blanchard, Guy Griebel, Robert J Blanchard
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 1, 2013
Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543Carine Dournes, Sandra Beeské, Catherine Belzung, et al.
European Journal of Pharmacology|February 26, 2003
The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panicD Caroline Blanchard, Guy Griebel, Robert J Blanchard
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Pharmacology, Biochemistry, and Behavior|June 7, 2005
CB1 receptor antagonists for the treatment of nicotine addictionCaroline Cohen, Ercem Kodas, Guy Griebel
Physiology & Behavior|September 27, 2005
Long-term impaired memory following predatory stress in miceWissam El Hage, Guy Griebel, Catherine Belzung
Pharmacology, Biochemistry, and Behavior|March 25, 2008
Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depressionDavid H Overstreet, Jeanne Stemmelin, Guy Griebel
The Journal of Clinical Psychiatry|November 14, 2012
The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studiesGuy Griebel, Sandra Beeské, Stephen M Stahl
Pharmacology, Biochemistry, and Behavior|March 2, 2011
The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in miceAlexandre Urani, Julie Philbert, Caroline Cohen, et al.
Behavioural Brain Research|May 8, 2012
Awakening properties of newly discovered highly selective H₃ receptor antagonists in ratsGuy Griebel, Michel Decobert, Agnès Jacquet, et al.
Pharmacology, Biochemistry, and Behavior|May 18, 2010
Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depressionDavid H Overstreet, V M Naimoli, Guy Griebel
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 9, 2003
Conditioning and residual emotionality effects of predator stimuli: some reflections on stress and emotionD Caroline Blanchard, Guy Griebel, Robert J Blanchard
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 1, 2013
Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543Carine Dournes, Sandra Beeské, Catherine Belzung, et al.
European Journal of Pharmacology|February 26, 2003
The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panicD Caroline Blanchard, Guy Griebel, Robert J Blanchard
Pageof 7